Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences
8/7/2012 6:30 AM EST
Raptor Pharmaceutical Corp.
Press release
Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences
NOVATO, Calif., 2012-08-07 12:30 CEST (GLOBE NEWSWIRE) -- Raptor Pharmaceutical
Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Ted
Daley, President of Raptor, will present an overview of the Company at two
investor conferences in August.
The conference presentation schedule is as follows:
Canaccord Genuity Annual Growth Conference
August 14, 2012 at 10:00am ET
InterContinental, Boston, MA
Wedbush PACGROW LIFE SCIENCES Management Access Conference
August 15, 2012 at 1:55pm ET
Le Parker Meridien, New York, NY
A live audio webcast and 14-day archive of the Canaccord and Wedbush
presentations will be available at http://ir.raptorpharma.com/events.cfm
About Raptor Pharmaceutical Corp.
Raptor Pharmaceutical Corp. (Nasdaq:RPTP) ("Raptor") seeks to research,
produce, and deliver medicines that improve life for patients with severe, rare
disorders. Raptor currently has product candidates in clinical development to
potentially treat nephropathic cystinosis, Non-alcoholic Steatohepatitis
("NASH"), Huntington's Disease ("HD"), aldehyde dehydrogenase deficiency
("ALDH2"), and thrombotic disorder.
Raptor's preclinical programs are based upon bioengineered novel drug
candidates and drug-targeting platforms derived from the human
receptor-associated protein and related proteins that are designed to target
cancer and infectious diseases.
For additional information, please visit www.raptorpharma.com.
The Raptor Pharmaceutical Corp. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=7180
CONTACT: Trout Group (investors)
Lauren Glaser
(646) 378-2972
EVC Group (media)
Janine McCargo
(646) 688-0425